CVS’ efforts to reform how its pharmacies are paid have reached a significant milestone that should stabilize flagging ...

Pharmacy benefit managers (PBMs) “invent all these special categories,” Cuban told Fortune’s Andrew Nusca. “They’re just ...

Mark Cuban is game to chat on social media—just not necessarily on X, formerly Twitter, he told the Fortune Brainstorm ...

Employee efficiency and productivity could plummet, too, not to mention the corrosion of company culture. For these reasons, ...

Amgen is on pace to return to its pre-Horizon capital structure by the end of 2025. Learn why I upgrade AMGN stock from hold ...

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Amazon.com, Inc. (AMZN), The Procter ...

Medicare Advantage continues to become increasingly popular among millions of Americans across the United States, but how do ...

American entrepreneur and investor Mark Cuban tells us why he and his partners launched the Mark Cuban Cost Plus Drug Company (MCCPDC), a public-benefit corporation and online pharmacy that ...

The Mark Cuban Cost Plus Drug Company (MCCPDC) – a public-benefit corporation and online pharmacy that launched in 2022 with a pledge to eliminate middlemen markups on off-patent drugs and pass ...

Drug pricing is influenced by numerous factors, but technology has the potential to strike the critical balance between ...

Medicare recipients who take expensive prescriptions will get a break this year with a $2,000 cap on drug costs.

This industry’s lobbying juggernaut has its claws in both sides of the aisle in Congress. In 2022, pharmaceutical and health ...